186
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Exploration into Plasma Hsa_circ_0052184 as a New Biomarker of Colorectal Cancer Prognosis

& ORCID Icon
Pages 589-597 | Received 22 Mar 2023, Accepted 26 May 2023, Published online: 12 Jun 2023
 

Abstract

Background

Circular RNAs (circRNAs) are strong modulators of tumor pathology. Herein, our goal was to examine the plasma hsa_circ_0052184 content among colorectal cancer (CRC) patients, and assess its association with patient clinicopathological profile and diagnostic values.

Methods

Overall, we collected 228 presurgical CRC and 146 normal plasma samples from The First People’s Hospital of Wenling. Circulating hsa_circ_0052184 levels were assessed via qRT-PCR, and the diagnostic prediction was conducted with the receiver operating characteristic (ROC) curve.

Results

Relative to healthy controls, CRC patients exhibited markedly enhanced circulating hsa_circ_0052184 levels, which were closely correlated with advanced stage of disease and worse outcome. Based on our uni- (UA) and multivariate assessments (MA), elevated hsa_circ_0052184 levels were a stand-alone predictor of poor prognosis. The ROC curve depicted an area under the curve (AUC) for CRC diagnosis to be 0.9072.

Conclusion

Circulating hsa_circ_0052184 is a potential bioindicator of CRC outcome.

Disclosure

No conflicts of interest to declare.

Additional information

Funding

There is no funding to report.